help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoneda, T.
Right arrow Articles by Mundy, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoneda, T.
Right arrow Articles by Mundy, G. R.

Molecular Endocrinology, Vol 7, 1313-1318, Copyright © 1993 by Endocrine Society

ARTICLES

Hormonal regulation of pp60c-src expression during osteoclast formation in vitro

T Yoneda, M Niewolna, C Lowe, E Izbicka and GR Mundy
Department of Medicine, University of Texas Health Science Center, San Antonio 78284-7877.

Recent studies have shown that the protooncogene c-src is required for normal osteoclastic bone resorption. In this study we examined the expression and regulation of pp60c-src in murine bone marrow cultures in which bone-resorbing multinucleated osteoclasts form over 6 days of culture. We found that both pp60c-src protein expression and pp60c-src tyrosine kinase activity correlated closely with the numbers of active osteoclasts in the cultures. PTH increased the numbers of osteoclasts, pp60c-src tyrosine kinase activity, and src protein, whereas calcitonin decreased the numbers of osteoclasts, src protein, and tyrosine kinase activity. However, when calcitonin was incubated for short periods (< 2 h) with the active osteoclasts present after 6 days of culture, there was a decrease in pp60c-src tyrosine kinase activity and the phosphorylation state, but not in total pp60c-src protein. These data suggest that pp60c-src is expressed in cultures of osteoclasts in parallel with the number of active bone-resorbing osteoclasts. They indicate that pp60c-src activity in osteoclast cultures depends on the activity and numbers of osteoclasts and is hormone regulated. As calcitonin receptors are detectable only in osteoclasts in these cultures, the inhibitory effects of calcitonin suggest that the critical site for pp60c-src expression in these cultures is in osteoclasts.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
E. Izbicka, T. Yoneda, Y. Takaoka, D. Horn, P. Williams, and G. R. Mundy
Identification of a Novel Bone/Calcium Metabolism-regulating Factor in Porcine Pancreas
J. Biol. Chem., September 20, 1996; 271(38): 23230 - 23234.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Feuerbach, R. Waelchli, T. Fehr, and J. H. M. Feyen
Mycotrienins
J. Biol. Chem., October 27, 1995; 270(43): 25949 - 25955.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society